1e
19
1
49
2
2
18
1b
1d
18
3c
57
1d
2 29
1d
25
Michelle Sara Gentile, MD, PhD
88
57
Associate Professor of Clinical Radiation Oncology
28
82
3
69
Ombudsperson, Department of Radiation Oncology, University of Pennsylvania
11
Department: Radiation Oncology
4
1
b
1d
46
Contact information
4e
4
3
3
3
2
4
b
1f
4e
Department of Radiation Oncology
23 University of Pennsylvania
1d Pennsylvania Hospital
19 800 Spruce Street
33 Widener Basement
Philadelphia, PA 19107
26
23 University of Pennsylvania
1d Pennsylvania Hospital
19 800 Spruce Street
33 Widener Basement
Philadelphia, PA 19107
2e
Office: 215-829-3873
32 Fax: 215-829-5424
24
af
12
32 Fax: 215-829-5424
24
13
Education:
21 7 BS 20 (Biological Sciences) c
3a University of Illinois at Chicago, 2003.
21 7 BA 1f (English Literature) c
3a University of Illinois at Chicago, 2003.
21 8 PhD 15 (Oncology) c
41 University of Cambridge, Trinity College, 2006.
21 7 MD c
30 Northwestern University, 2010.
c
3
3
3
3
8d
Permanent link21 7 BS 20 (Biological Sciences) c
3a University of Illinois at Chicago, 2003.
21 7 BA 1f (English Literature) c
3a University of Illinois at Chicago, 2003.
21 8 PhD 15 (Oncology) c
41 University of Cambridge, Trinity College, 2006.
21 7 MD c
30 Northwestern University, 2010.
c
2 29
21
1e
1d
24
2b
29
27
23
159 Rogacki K, Teo PT, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M.: Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiotherapy for Head and Neck Cancer Advances in Rad Onc 15(9): 101545, Aug 2024.
18b Deepak Lakshmipathy BS, Eric Winter MD, Christian Fritz MD, Jacob Harris BA, Michelle Gentile MD, PhD, Alvaro Moreira MD, Karthik Rajasekaran MD: Managing Vestibular Schwannomas with Radiosurgery and Radiotherapy: AGREE II Appraisal of Clinical Practice Guidelines. J Med Imaging and Radiat Oncol 68(4): 462-471, Jun 2024.
171 Teo PT, Rogacki K, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M: Determining Risk and Predictors of Head and Neck Cancer Treatment-Related Lymphedema: A Clinicopathologic and Dosimetric Data Mining Approach Using Interpretable Machine Learning and Ensemble Feature Selection. Clin Transl Radiat Oncol 1e Feb 2024.
188 O'Reilly S, Kurtz G, Gentile M, Lukens N, Lin A, Alonso-Basanta M, Li T, Dong L, Zou W, Teo K: Quantifying Patient Dose Sparing Achieved using Reduced Range Uncertainty Margins with DECT-Calculated SPR for H&N and CNS Therapy Patients. American Association of Physicists in Medicine Annual Meeting, Houston TX Jul 2023.
15f O'Reilly S, Kurtz G, Gentile M, Lukens N, Lin A, Alonso-Basanta M, Li T, Dong L, Zou W, Teo K: Inter and Intra Scanner Reproducibility of DECT Calculated SPR for Proton Dose Calculation Particle Therapy Co-Operative Group Annual Meeting, Madrid Spain 2023 Jun 2023 Notes: Oral.
148 Berlin E, Yegya-Raman N, Hollawell C, Haertter A, Rhodes S, Seol S, Gentile M, Li T, Freeman G, Taunk NK: Breast Reconstruction Complications Following Post-Mastectomy Proton Radiotherapy for Breast Cancer. Advances in Radiat Oncol 9(3): 101385, Mar 2023.
1cd Anstadt E, Carey RM, Shimunov D, Lin A, Barskey AR, CM Wright, Doucette A, Gentile M, Cohen R, Lova S, Weinstein G, O'Malley Jr. B, Chalian A, Rassekh C, Rajasekaran K, Basu D, Cannady SB, Brody R, Farwell G, Lukens JN. : Outcomes After TORS or Definitive Chemoradiation for T3/T4 HPV positive Oropharynx Cancer. American Radium Society Annual Meeting, Scottsdale AZ Nov 2022 Notes: Oral.
11a Rhodes SS, Berlin E, Yegya-Raman N, Doucette A, Gentile M, Freedman GM, Taunk NL: Factors Associated with Travel Distance in the Receipt of Proton Breast Radiation Therapy. Int J Part Ther 9(3): 1-9, Sep 2022.
83 Teo PT, Rogacki K, Gopalakrishnan M, Cutright D, Mittal B, Das I, Abazeed ME, Gentile M 2 117 : Determining the Predictors of Radiation–Induced Lymphedema for Head & Neck Cancer Patients using Ensemble Feature Selection and Machine Learning. American Association of Physicists in Medicine Annual Meeting, Washington DC Jul 2022 Notes: Oral.
2c
7
1d
1f
Selected Publications
198 Gobillot TA, Weinstein G, Cao A, Lee JJ, Brody RM, Basu D, O'Malley Jr BW, Farwell DG, Cannady S, Lin A, Lukens J, Gentile M, Newman JG, Chalian AA, Sun L, Lakshmipathy D, Cohen RB, Rasskeh CH, Rajasekaran K: Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery. The Laryngoscope July 2025.159 Rogacki K, Teo PT, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M.: Clinical, Pathologic, and Dosimetric Predictors of Head and Neck Lymphedema Following Definitive or Adjuvant Radiotherapy for Head and Neck Cancer Advances in Rad Onc 15(9): 101545, Aug 2024.
18b Deepak Lakshmipathy BS, Eric Winter MD, Christian Fritz MD, Jacob Harris BA, Michelle Gentile MD, PhD, Alvaro Moreira MD, Karthik Rajasekaran MD: Managing Vestibular Schwannomas with Radiosurgery and Radiotherapy: AGREE II Appraisal of Clinical Practice Guidelines. J Med Imaging and Radiat Oncol 68(4): 462-471, Jun 2024.
171 Teo PT, Rogacki K, Gopalakrishnan M, Das IJ, Abazeed ME, Mittal BB, Gentile M: Determining Risk and Predictors of Head and Neck Cancer Treatment-Related Lymphedema: A Clinicopathologic and Dosimetric Data Mining Approach Using Interpretable Machine Learning and Ensemble Feature Selection. Clin Transl Radiat Oncol 1e Feb 2024.
188 O'Reilly S, Kurtz G, Gentile M, Lukens N, Lin A, Alonso-Basanta M, Li T, Dong L, Zou W, Teo K: Quantifying Patient Dose Sparing Achieved using Reduced Range Uncertainty Margins with DECT-Calculated SPR for H&N and CNS Therapy Patients. American Association of Physicists in Medicine Annual Meeting, Houston TX Jul 2023.
15f O'Reilly S, Kurtz G, Gentile M, Lukens N, Lin A, Alonso-Basanta M, Li T, Dong L, Zou W, Teo K: Inter and Intra Scanner Reproducibility of DECT Calculated SPR for Proton Dose Calculation Particle Therapy Co-Operative Group Annual Meeting, Madrid Spain 2023 Jun 2023 Notes: Oral.
148 Berlin E, Yegya-Raman N, Hollawell C, Haertter A, Rhodes S, Seol S, Gentile M, Li T, Freeman G, Taunk NK: Breast Reconstruction Complications Following Post-Mastectomy Proton Radiotherapy for Breast Cancer. Advances in Radiat Oncol 9(3): 101385, Mar 2023.
1cd Anstadt E, Carey RM, Shimunov D, Lin A, Barskey AR, CM Wright, Doucette A, Gentile M, Cohen R, Lova S, Weinstein G, O'Malley Jr. B, Chalian A, Rassekh C, Rajasekaran K, Basu D, Cannady SB, Brody R, Farwell G, Lukens JN. : Outcomes After TORS or Definitive Chemoradiation for T3/T4 HPV positive Oropharynx Cancer. American Radium Society Annual Meeting, Scottsdale AZ Nov 2022 Notes: Oral.
11a Rhodes SS, Berlin E, Yegya-Raman N, Doucette A, Gentile M, Freedman GM, Taunk NL: Factors Associated with Travel Distance in the Receipt of Proton Breast Radiation Therapy. Int J Part Ther 9(3): 1-9, Sep 2022.
83 Teo PT, Rogacki K, Gopalakrishnan M, Cutright D, Mittal B, Das I, Abazeed ME, Gentile M 2 117 : Determining the Predictors of Radiation–Induced Lymphedema for Head & Neck Cancer Patients using Ensemble Feature Selection and Machine Learning. American Association of Physicists in Medicine Annual Meeting, Washington DC Jul 2022 Notes: Oral.
2c